Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-26

FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved pantoprazole sodium delayed-release through an original application for Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium delayed-release (pantoprazole sodium)

Snippet

ORIG AP for PANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM DELAYED-RELEASE)